Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders

Annals of Neurology

Volumn 78, Issue 5, 2015, Pages 814-823

  Yatsuga, Shuichi ^a   Fujita, Yasunori ^b   Ishii, Akiko ^c   Fukumoto, Yoshihiro ^a   Arahata, Hajime ^d   Kakuma, Tatsuyuki ^e   Kojima, Toshio ^f   Ito, Masafumi ^b   Tanaka, Masashi ^b   Saiki, Reo ^a   Koga, Yasutoshi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d Omuta National Hospital   (Japan)

^e Kurume University Graduate School of Medicine Kurume University Graduate School of Medicine Graduate School Biostatistics   (Japan)

^f TOYOHASHI UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 15; CREATINE KINASE; FIBROBLAST GROWTH FACTOR 21; LACTIC ACID; FIBROBLAST GROWTH FACTOR; GDF15 PROTEIN, HUMAN; GROWTH DIFFERENTIATION FACTOR 15; PYRUVIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JAPANESE MITOCHONDRIAL DISEASE RATING SCALE; KEARNS SAYRE SYNDROME; LEIGH DISEASE; MALE; MELAS SYNDROME; MITOCHONDRIAL ENCEPHALOPATHY; NEWCASTLE MITOCHONDRIAL DISEASE RATING SCALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ADOLESCENT; BLOOD; CHILD; GENETICS; MIDDLE AGED; MITOCHONDRIAL DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CHILD; CREATINE KINASE; FEMALE; FIBROBLAST GROWTH FACTORS; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; LACTIC ACID; MALE; MELAS SYNDROME; MIDDLE AGED; MITOCHONDRIAL DISEASES; PYRUVIC ACID; ROC CURVE; YOUNG ADULT;

EID: 84945124030     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24506     Document Type: Article

References (24)

1. Haas RH, Parikh S, Falk MJ, et al., Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 2007; 120: 1326-1333.
2. Munnich A, Rotig A, Chretien D, et al., Clinical presentation of mitochondrial disorders in childhood. J Inherit Metab Dis 1996; 19: 521-527.
3. Suomalainen A, Elo JM, Pietiläinen KH, et al., FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol 2011; 10: 806-818.
4. Davis RL, Liang C, Edema-Hildebrand F, et al., Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology 2013; 81: 1819-1826.
5. Liang C, Ahmad K, Sue CM,. The broadening spectrum of mitochondrial disease: shifts in the diagnostic paradigm. Biochim Biophys Acta 2014; 1840: 1360-1367.
6. Fujita Y, Ito M, Kojima T, et al., GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases. Mitochondrion 2014; 20: 34-42.
7. Lindahl B,. The story of growth differentiation factor 15: another piece of the puzzle. Clin Chem 2013; 59: 1550-1552.
8. Kalko SG, Paco S, Jou C, et al., Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies. BMC Genomics 2014; 15: 91.
9. Yatsuga S, Povalko N, Nishioka J, et al., MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta 2012; 1820: 619-624.
10. Schaefer AM, Phoenix C, Elson JL, et al., Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology 2006; 66: 1932-1934.
11. Delong ER, Delong DM, Clarke-Pearson DL,. Comparing the area under two or more correlated receiver operating characteristic curves: a non parametric approach. Biometrics. 1988; 44: 837-845.
12. Cantó C, Auwerx J,. FGF21 takes a fat bite. Science 2012; 336: 675-676.
13. Lambrecht S, Smith V, De Wilde K, et al., Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development. Arthritis Rheumatol 2014; 66: 418-427.
14. Yang CZ, Ma J, Luo QQ, et al., Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma. J Oral Pathol Med 2014; 43: 28-34.
15. Cui R, Gale RP, Zhu G, et al., Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions. Leuk Res 2014; 38: 545-550.
16. Tarkun P, Mehtap O, Atesoglu EB, et al., Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemia. Eur J Haematol 2013; 91: 228-235.
17. Shalev H, Phillip M, Galil A, et al., High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type I. Eur J Haematol 2013; 90: 31-36.
18. Schiegnitz E, Kammerer PW, Koch FP, et al., GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma. Oral Oncol 2012; 48: 608-614.
19. Santhanakrishnan R, Chong JPC, Ng TP, et al., Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction. Eur J Heart Fail 2012; 14: 1338-1347.
20. Harding HP, Zhang Y,., Zeng H, et al., An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003; 11: 619-633.
21. Jousse C, Deval C, Maurin AC, et al., TRB3 inhibits the transcriptional activation of stress-regulated genes by a negative feedback on the ATF4 pathway. J Biol Chem 2007; 282: 15851-15861.
22. De Sousa-Coelho AL, Marrero PF,., Haro D,. Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation. Biochem J 2012; 443: 165-171.
23. Jiang S, Yan C,., Fang QC, et al., Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis. J Biol Chem 2014; 289: 29751-29765.
24. Kim KH, Jeong YT, Kim SH, et al., Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation. Biochem Biophys Res Commun 2013; 440: 76-81.